Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya

Introduction. To stop SARS-CoV-2 from spreading, it's crucial to have a solid understanding of the baseline characteristics of demographic variables, clinical symptoms, and comorbidity so that quarantining and testing protocols can be developed. Material and methods. A retrospective study wa...

Full description

Bibliographic Details
Main Authors: Hanan AQEEHAL, Ahmed ALARBI, Haytham MANEEA, Mahmud BENMANSUR, Abdelhadi ELTURKI, Anud ZAABIA, Rachid BENTOUTA, Jebril GEBRIL
Format: Article
Language:English
Published: Asociatia de Biosiguranta si Biosecuritate 2022-01-01
Series:One Health & Risk Management
Subjects:
Online Access:https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/282
_version_ 1811319340642861056
author Hanan AQEEHAL
Ahmed ALARBI
Haytham MANEEA
Mahmud BENMANSUR
Abdelhadi ELTURKI
Anud ZAABIA
Rachid BENTOUTA
Jebril GEBRIL
author_facet Hanan AQEEHAL
Ahmed ALARBI
Haytham MANEEA
Mahmud BENMANSUR
Abdelhadi ELTURKI
Anud ZAABIA
Rachid BENTOUTA
Jebril GEBRIL
author_sort Hanan AQEEHAL
collection DOAJ
description Introduction. To stop SARS-CoV-2 from spreading, it's crucial to have a solid understanding of the baseline characteristics of demographic variables, clinical symptoms, and comorbidity so that quarantining and testing protocols can be developed. Material and methods. A retrospective study was conducted on COVID-19 Laboratory confirmed cases. Data were collected by using kobo toolbox, demographic variables, clinical symptoms, and Comorbidity was considered. Yates-corrected chi2 tests and Multinomial Logistic Regression was used to estimate the odds ratio (OR) and 95% confidence interval (CI) of factors and their impact on COVID-19 prevalence. Results. A total of 6302 of which 3536(56.1%) men and 2766 (44%) women with a mean age (±SD) of 44±17.6 years were included within the study. Clinical symptoms and Comorbidity were significant for both sexes p<0.0001. Multinomial Logistic Regression confirmed that age <55, 3 or more symptoms (OR=1.130 CI95% 1.013-1.261) and 3 or more comorbidities (OR=1.035 Cl95% 0.942-1.137) were a significant risk factor for COVID-19 prevalence in male patients, among women, age 85>/=, 3 or more symptoms (p<0.0001, OR=1.995 CI95% 1.335-2.992) and 3 or more comorbidities (p<0.0001, OR=1.538 Cl95% 1.045-2.640) were significant risk factor for COVID-19 prevalence in females. Conclusions. Our study suggests that the prevalence of COVID-19 patients and symptoms was higher in men than women. The high prevalence of smoking could have contributed to the high prevalence of COVID-19 among men. Study also suggests that the presence of at least one or combined comorbidities are risk factors of COVID-19 prevalence and a potential risk factor COVID-19 - related outcomes. More efforts should be exercised to protect patients with one or more comorbidities from being exposed to infection.
first_indexed 2024-04-13T12:40:52Z
format Article
id doaj.art-490820abd1ce473eadaa295ccc435b87
institution Directory Open Access Journal
issn 2887-3458
2587-3466
language English
last_indexed 2024-04-13T12:40:52Z
publishDate 2022-01-01
publisher Asociatia de Biosiguranta si Biosecuritate
record_format Article
series One Health & Risk Management
spelling doaj.art-490820abd1ce473eadaa295ccc435b872022-12-22T02:46:31ZengAsociatia de Biosiguranta si BiosecuritateOne Health & Risk Management2887-34582587-34662022-01-0131293710.38045/ohrm.2022.1.04Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in LibyaHanan AQEEHAL0https://orcid.org/0000-0003-0601-7009Ahmed ALARBI1https://orcid.org/0000-0002-5365-2876Haytham MANEEA2https://orcid.org/0000-0003-1416-8851Mahmud BENMANSUR3https://orcid.org/0000-0001-5239-2657Abdelhadi ELTURKI4https://orcid.org/0000-0002-1283-3953Anud ZAABIA5https://orcid.org/0000-0003-3347-3720Rachid BENTOUTA6https://orcid.org/0000-0002-5919-2452Jebril GEBRIL7https://orcid.org/0000-0002-4500-7834National Centre for Disease Control, Ministry of HealthNational Centre for Disease Control, Ministry of HealthNational Centre for Disease Control, Ministry of HealthNational Centre for Disease Control, Ministry of HealthNational Centre for Disease Control, Ministry of HealthNational Centre for Disease Control, Ministry of HealthNational Centre for Disease Control, Ministry of HealthNational Centre for Disease Control, Ministry of HealthIntroduction. To stop SARS-CoV-2 from spreading, it's crucial to have a solid understanding of the baseline characteristics of demographic variables, clinical symptoms, and comorbidity so that quarantining and testing protocols can be developed. Material and methods. A retrospective study was conducted on COVID-19 Laboratory confirmed cases. Data were collected by using kobo toolbox, demographic variables, clinical symptoms, and Comorbidity was considered. Yates-corrected chi2 tests and Multinomial Logistic Regression was used to estimate the odds ratio (OR) and 95% confidence interval (CI) of factors and their impact on COVID-19 prevalence. Results. A total of 6302 of which 3536(56.1%) men and 2766 (44%) women with a mean age (±SD) of 44±17.6 years were included within the study. Clinical symptoms and Comorbidity were significant for both sexes p<0.0001. Multinomial Logistic Regression confirmed that age <55, 3 or more symptoms (OR=1.130 CI95% 1.013-1.261) and 3 or more comorbidities (OR=1.035 Cl95% 0.942-1.137) were a significant risk factor for COVID-19 prevalence in male patients, among women, age 85>/=, 3 or more symptoms (p<0.0001, OR=1.995 CI95% 1.335-2.992) and 3 or more comorbidities (p<0.0001, OR=1.538 Cl95% 1.045-2.640) were significant risk factor for COVID-19 prevalence in females. Conclusions. Our study suggests that the prevalence of COVID-19 patients and symptoms was higher in men than women. The high prevalence of smoking could have contributed to the high prevalence of COVID-19 among men. Study also suggests that the presence of at least one or combined comorbidities are risk factors of COVID-19 prevalence and a potential risk factor COVID-19 - related outcomes. More efforts should be exercised to protect patients with one or more comorbidities from being exposed to infection.https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/282sars-cov-2comorbidityclinical symptomslibya
spellingShingle Hanan AQEEHAL
Ahmed ALARBI
Haytham MANEEA
Mahmud BENMANSUR
Abdelhadi ELTURKI
Anud ZAABIA
Rachid BENTOUTA
Jebril GEBRIL
Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya
One Health & Risk Management
sars-cov-2
comorbidity
clinical symptoms
libya
title Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya
title_full Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya
title_fullStr Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya
title_full_unstemmed Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya
title_short Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya
title_sort retrospective study on the prevalence of covid 19 confirmed cases and evidence of gender bias in libya
topic sars-cov-2
comorbidity
clinical symptoms
libya
url https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/282
work_keys_str_mv AT hananaqeehal retrospectivestudyontheprevalenceofcovid19confirmedcasesandevidenceofgenderbiasinlibya
AT ahmedalarbi retrospectivestudyontheprevalenceofcovid19confirmedcasesandevidenceofgenderbiasinlibya
AT haythammaneea retrospectivestudyontheprevalenceofcovid19confirmedcasesandevidenceofgenderbiasinlibya
AT mahmudbenmansur retrospectivestudyontheprevalenceofcovid19confirmedcasesandevidenceofgenderbiasinlibya
AT abdelhadielturki retrospectivestudyontheprevalenceofcovid19confirmedcasesandevidenceofgenderbiasinlibya
AT anudzaabia retrospectivestudyontheprevalenceofcovid19confirmedcasesandevidenceofgenderbiasinlibya
AT rachidbentouta retrospectivestudyontheprevalenceofcovid19confirmedcasesandevidenceofgenderbiasinlibya
AT jebrilgebril retrospectivestudyontheprevalenceofcovid19confirmedcasesandevidenceofgenderbiasinlibya